- Home
- NEOG vs DYN Comparison
NEOG vs DYN Comparison
Compare NEOG & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOG
- DYN
- Stock Information
- Founded
- NEOG 1981
- DYN 1984
- Country
- NEOG United States
- DYN United States
- Employees
- NEOG N/A
- DYN N/A
- Industry
- NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DYN Medicinal Chemicals and Botanical Products
- Sector
- NEOG Health Care
- DYN Health Care
- Exchange
- NEOG Nasdaq
- DYN Nasdaq
- Market Cap
- NEOG 3.2B
- DYN 2.6B
- IPO Year
- NEOG 1989
- DYN 2020
- Fundamental
- Price
- NEOG $10.04
- DYN $14.01
- Analyst Decision
- NEOG Buy
- DYN Strong Buy
- Analyst Count
- NEOG 2
- DYN 10
- Target Price
- NEOG $14.00
- DYN $50.78
- AVG Volume (30 Days)
- NEOG 2.2M
- DYN 2.2M
- Earning Date
- NEOG 04-08-2025
- DYN 03-04-2025
- Dividend Yield
- NEOG N/A
- DYN N/A
- EPS Growth
- NEOG N/A
- DYN N/A
- EPS
- NEOG N/A
- DYN N/A
- Revenue
- NEOG $913,828,000.00
- DYN N/A
- Revenue This Year
- NEOG $0.46
- DYN N/A
- Revenue Next Year
- NEOG $4.12
- DYN N/A
- P/E Ratio
- NEOG N/A
- DYN N/A
- Revenue Growth
- NEOG N/A
- DYN N/A
- 52 Week Low
- NEOG $9.70
- DYN $13.07
- 52 Week High
- NEOG $18.58
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- NEOG 34.46
- DYN 37.85
- Support Level
- NEOG $9.70
- DYN $13.59
- Resistance Level
- NEOG $10.41
- DYN $14.50
- Average True Range (ATR)
- NEOG 0.32
- DYN 0.98
- MACD
- NEOG 0.01
- DYN 0.32
- Stochastic Oscillator
- NEOG 22.22
- DYN 22.90
About NEOG Neogen Corporation
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.